Analyst, Modelling (Health Economics & Outcomes Research)
Inizio
About this role
We are seeking a health economics analyst to join our HEOR Modelling team, specializing in developing and interpreting health economic models for health technology assessment. The role offers opportunities for professional growth, working on global projects, and contributing to HTA submissions.
Skills
Qualifications
About Inizio
inizio.comInizio is a healthcare and life-sciences consulting firm that helps organisations unlock the value of their innovations by connecting best‑in‑class strategic, analytic and creative capabilities. They deliver integrated services—strategy, analytics and creative execution—to commercialise and communicate new therapies, devices and services. Inizio emphasizes data‑driven insights and cross‑disciplinary teams to accelerate adoption, demonstrate value and drive growth for clients across healthcare and life sciences.
Recent company news
Inizio elevates COO Ryan Quigley to chief executive
Sep 10, 2025
Inizio names CEO as Paul Taaffe departs role
Sep 9, 2025
Inizio Taps Ryan Quigley as CEO
Sep 9, 2025
Inizio names Ryan Quigley CEO
Sep 9, 2025
Q&A with Ryan Quigley, CEO of Inizio
Nov 24, 2025
About Inizio
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Inizio.
Salary
$200k – $240k
per year
More jobs at Inizio
Similar Jobs
Global HEOR Economic Modelling Senior Associate
Amgen
Global HEOR Economic Modelling Senior Associate
Amgen
Global HEOR Economic Modelling Senior Associate
Amgen
Sr Principal - Analyst; Economic Modelling
LI Test Company
Gulf Health Economics & Outcomes Research Manager
MSD
Director, Field Health Economics & Outcomes Research (HEOR)
Nuvalent, Inc.